Background: Glyphosate is the most commonly used herbicide worldwide, with both residential and agricultural uses. In 2015, the International Agency for Research on Cancer classified glyphosate as "probably carcinogenic to humans," noting strong mechanistic evidence and positive associations for non-Hodgkin lymphoma (NHL) in some epidemiologic studies. A previous evaluation in the Agricultural Health Study (AHS) with follow-up through 2001 found no statistically significant associations with glyphosate use and cancer at any site.

Methods: The AHS is a prospective cohort of licensed pesticide applicators from North Carolina and Iowa. Here, we updated the previous evaluation of glyphosate with cancer incidence from registry linkages through 2012 (North Carolina)/2013 (Iowa). Lifetime days and intensity-weighted lifetime days of glyphosate use were based on self-reported information from enrollment (1993-1997) and follow-up questionnaires (1999-2005). We estimated incidence rate ratios (RRs) and 95% confidence intervals (CIs) using Poisson regression, controlling for potential confounders, including use of other pesticides. All statistical tests were two-sided.

Results: Among 54 251 applicators, 44 932 (82.8%) used glyphosate, including 5779 incident cancer cases (79.3% of all cases). In unlagged analyses, glyphosate was not statistically significantly associated with cancer at any site. However, among applicators in the highest exposure quartile, there was an increased risk of acute myeloid leukemia (AML) compared with never users (RR = 2.44, 95% CI = 0.94 to 6.32, Ptrend = .11), though this association was not statistically significant. Results for AML were similar with a five-year (RRQuartile 4 = 2.32, 95% CI = 0.98 to 5.51, Ptrend = .07) and 20-year exposure lag (RRTertile 3 = 2.04, 95% CI = 1.05 to 3.97, Ptrend = .04).

Conclusions: In this large, prospective cohort study, no association was apparent between glyphosate and any solid tumors or lymphoid malignancies overall, including NHL and its subtypes. There was some evidence of increased risk of AML among the highest exposed group that requires confirmation.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6279255PMC
http://dx.doi.org/10.1093/jnci/djx233DOI Listing

Publication Analysis

Top Keywords

glyphosate cancer
12
glyphosate
9
cancer incidence
8
agricultural health
8
health study
8
previous evaluation
8
prospective cohort
8
lifetime days
8
increased risk
8
cancer
5

Similar Publications

Glyphosate [N-(phosphonomethyl) glycine], a systemic herbicide, is used globally (825 million kg/year) in 750+ formulations. The International Agency for Research on Cancer classified glyphosate is a probable human carcinogen (Group 2A), but epidemiological studies have been lacking for its association with liver cancer and chronic liver disease. We analyzed urine specimens from 591 patients with newly diagnosed liver cancer, chronic liver disease (CLD), and healthy individuals from five different medical centers between 2011 to 2016 in Thailand.

View Article and Find Full Text PDF

Glyphosate exposure exacerbates neuroinflammation and Alzheimer's disease-like pathology despite a 6-month recovery period in mice.

J Neuroinflammation

December 2024

Arizona State University-Banner Neurodegenerative Disease Research Center at the Biodesign Institute, Arizona State University, Tempe, AZ, USA.

Article Synopsis
  • Glyphosate usage has risen significantly in the U.S. since 1996, with research showing it can accumulate in the brain and invoke neuroinflammation, potentially influencing neurodegenerative disorders like Alzheimer's Disease (AD).
  • The study involved giving varied doses of glyphosate to both Alzheimer's model mice and control mice, revealing that glyphosate and its metabolite remained detectable in brain tissue even after a recovery period.
  • Results indicated that glyphosate exposure led to worsened cognitive function in AD mice, along with significant increases in brain plaque formation, tau protein abnormalities, and persistent inflammatory markers in both mouse groups.
View Article and Find Full Text PDF

Comprehensive risk-benefit assessment of chemicals: A case study on glyphosate.

Toxicol Rep

December 2024

Independent scientist, Johnsonville, 6 Johnsonville Road, Wellington 6037, New Zealand.

The integrity of environmental toxicology is undermined by selective risk assessments that focus intently on certain chemicals while overlooking others. Glyphosate, one of the most widely used herbicides, serves as a case study of how regulatory decisions can be shaped by incomplete or biased evidence. This paper argues for a holistic approach to toxicology, calling for balanced assessments that consider both health risks and societal benefits.

View Article and Find Full Text PDF

Pesticides and risk of pancreatic adenocarcinoma in France: a nationwide spatiotemporal ecological study between 2011 and 2021.

Eur J Epidemiol

November 2024

ULR 2694-METRICS: Évaluation Des Technologies de Santé Et Des Pratiques Médicales, University of Lille, CHU Lille, 59000, Lille, France.

While pancreatic adenocarcinoma (PA) incidence is increasing, especially in France, the association between pesticides and PA remains unclear. The aims of this study were to assess the spatiotemporal distribution of the incidence of PA in France between 2011 and 2021 and to determine whether pesticide exposure was associated with higher risk of PA. We employed a disease-mapping and ecological regression approach with medicoadministrative data covering 99% of the French population.

View Article and Find Full Text PDF
Article Synopsis
  • Glyphosate, a commonly used herbicide, has an unclear relationship with kidney stones, prompting this study to investigate its impact, potential mediating factors, and at-risk populations.
  • Utilizing data from the National Health and Nutrition Examination Survey (NHANES) from 2013-2018, researchers found that participants with higher urinary glyphosate levels had a significantly increased prevalence of kidney stones.
  • The study revealed that the association was stronger in men, non-Hispanic whites, and those with hypertension, and also identified certain serum markers that partially mediated this relationship.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!